ID
22310
Beschrijving
A Post-Approval Pharmacokinetic Study of Bortezomib in Participants With Multiple Myeloma; ODM derived from: https://clinicaltrials.gov/show/NCT01801436
Link
https://clinicaltrials.gov/show/NCT01801436
Trefwoorden
Versies (1)
- 29-05-17 29-05-17 -
Geüploaded op
29 mei 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Multiple Myeloma NCT01801436
Eligibility Multiple Myeloma NCT01801436
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
prior therapy, bortezomib, progressive disease
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1176309
- UMLS CUI [1,3]
- C1335499
Beschrijving
prior therapy bortezomib, serious adverse event
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C1514463
- UMLS CUI [1,2]
- C1176309
- UMLS CUI [1,3]
- C1519255
Beschrijving
nitrosoureas, prior chemotherapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C3540781
- UMLS CUI [2]
- C1514457
Beschrijving
steroid therapy
Datatype
boolean
Alias
- UMLS CUI [1]
- C0149783
Beschrijving
hiv, hep b, hep c
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0019682
- UMLS CUI [1,2]
- C0019163
- UMLS CUI [1,3]
- C0019196
Similar models
Eligibility Multiple Myeloma NCT01801436
- StudyEvent: Eligibility
C0026764 (UMLS CUI [1,2])
C0026764 (UMLS CUI [2,1])
C0035020 (UMLS CUI [2,2])
C1335499 (UMLS CUI [2,3])
C0815189 (UMLS CUI [2,4])
C0015787 (UMLS CUI [2])
C0700589 (UMLS CUI [3])
C1176309 (UMLS CUI [1,2])
C1335499 (UMLS CUI [1,3])
C1176309 (UMLS CUI [1,2])
C1519255 (UMLS CUI [1,3])
C1514457 (UMLS CUI [2])
C0019163 (UMLS CUI [1,2])
C0019196 (UMLS CUI [1,3])